4th Quarter - Report
TEVA PHARMACEUTICALS USA, INC. for TEVA PHARMACEUTICALS USA INC
Client
Income
—
Expenses
$700,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Medicaid Rebate provision of the Bipartisan Budget Act of 2015; the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act"); HR 2051-FAST Generics Act; S.771-Improving Access to Affordable Drugs Act; HR 749-Lower Drugs Through Competition Act; and Administration review of drug pricing policies.
Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as the indirect parent of Teva Pharmaceuticals USA Inc., has an interest in the issues listed.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES M. FENTON | — |
| DOLLY A JUDGE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.